Post by
HawkII on Jun 24, 2019 9:21am
CRFTy press releases
What a great deal for shareholders ... NOT!. Today's news about CBD Therapeutics is old and already known from CRFT's Listing Statement on SEDAR, specifically (pg 7) "On November 7, 2018, Pasha completed the acquisition of all of the issued and outstanding share capital of 1160899 B.C. Ltd. (d/b/a CBD Therapeutics)" and (pg 135) "As consideration, the Company has the following commitments ... iii. 50,000,000 common shares of the Company at the date of closing (issued)". The acquisition was $14mm (cash +shares) + $1.4mm in finder common shares, which seems a lot for a business that is described in their MD&A as a business that "did not have inputs, processes and outputs in place that constituted a business under IFRS3".
Comment by
Gnomoney on Jun 25, 2019 10:12am
If the changes made bring about positive results, I say bring them on.
Comment by
knowSomething on Jun 25, 2019 11:04am
Glad to see people practicing due diligence. The team leading this group should be scrutinized as I’m seeing some sleazy deals and operations going on IMHO. Setting buy at .30 and even questioning that.
Comment by
Gnomoney on Jun 26, 2019 8:39am
I don't think you will see it get that low again, it dipped quite low when the new team took over and began a slow rise. I think that you will see more up than down movement, particularily this fall/winter, I predict a winfall for the hangers on. IMHO....GLTA.... Always invest what you can afford to do without...losing really SUCKS!
Comment by
hiheyhello on Jun 26, 2019 9:57am
This post has been removed in accordance with Community Policy
Comment by
MSWHoldings on Jun 29, 2019 12:21pm
Yes, it is fully Trademark infringing. If you google "CBD Therapeutics" you sill notice all the spots all over the web where the CRFT brand and trademarks are used. The other CBDT, is fully infringing and there is ongoing legal action from my understanding.